T1	Participants 116 154	advanced head and neck cancer patients
T2	Participants 522 565	patients with advanced head and neck cancer
T3	Participants 587 762	successive patients with unresectable grade I/II head and neck cancer who were not suitable for irradiation treatment (T any N3 or T4 N2C), metastatic or previously irradiated
T4	Participants 764 804	All patients gave their informed consent
T5	Participants 806 886	A joint ear, nose and throat (ENT) oncological committee performed the selection
T6	Participants 888 938	A total of 170 patients were included in the study
T7	Participants 3186 3215	head and neck cancer patients
